26.5 C
Vientiane
Friday, September 12, 2025
spot_img
Home Blog Page 2211

OCBC Cycle Fun Space at Singapore Festival 2023 on 18-19 November

Calling families and kids interested in Singaporean food and culture

HONG KONG SAR – Media OutReach – 14 November 2023 – OCBC Bank (Hong Kong) Limited (“OCBC Hong Kong”) presents OCBC Cycle Fun Space at Singapore Festival 2023 on 18-19 November 2023 at Central Market, joining hand with our trusted partner The Singapore Chamber of Commerce Hong Kong.

A3 Poster_Output.jpg

As a Bank that advocates Singaporean culture and sustainable and healthy lifestyle, OCBC Hong Kong invites families and kids to participate in some exciting activities including Singapore traditional games, ‘SG-HK’ virtual bike challenge and balance bike experience. On top, anyone who pre-registers for Singapore Festival 2023 can get freebies at the on-site reception counter, and participate in activities such as face painting, balloon twister and others for free!

OCBC Cycle is an annual mass participation cycling game event organised by OCBC Group in Singapore attracting more than 9,000 passionate cyclists every year. It aims to be a safe cycling platform for riders across all cycling proficiencies. OCBC Hong Kong brings the Group’s passion for cycling to the local community, solidifying its “One Group” approach.

Save the date and see you there!

OCBC Cycle Fun Space
Date: 18 – 19 November 2023
Time: 12 noon to 10 pm
Location: Singapore Festival 2023

Central Market, Ground Floor

OCBC Booth & OCBC Cycle Fun Space

Central Market, Ground Floor (G08 booth) and 1/F Event Space

Register: https://events.singaporeglobalnetwork.gov.sg/singapore-festival-hong-kong-2023-kjxhf

Hashtag: #OCBCHongKong

The issuer is solely responsible for the content of this announcement.

About OCBC

OCBC is the longest established Singapore bank, formed in 1932 from the merger of three local banks, the oldest of which was founded in 1912. It is one of the world’s most highly-rated banks, with Aa1 by Moody’s and AA- by both Fitch and S&P. Recognised for its financial strength and stability, OCBC is consistently ranked among the World’s Top 50 Safest Banks by Global Finance and has been named Best Managed Bank in Singapore by The Asian Banker.

OCBC is the second largest financial services group in Southeast Asia by assets. The Group offers a broad array of commercial banking, specialist financial and wealth management services, ranging from consumer, corporate, investment, private and transaction banking to treasury, insurance, asset management and stockbroking services.

OCBC’s private banking services are provided by its wholly-owned subsidiary Bank of Singapore, which operates on a unique open-architecture product platform to source for the best-in-class products to meet its clients’ goals. Its insurance subsidiary, Great Eastern Holdings, is the oldest and most established life insurance group in Singapore and Malaysia. Its asset management subsidiary, Lion Global Investors, is one of the leading asset management companies in Southeast Asia.

The Group’s key markets are Singapore, Malaysia, Indonesia and Greater China. It has more than 410 branches and representative offices in 19 countries and regions.

For more information, please visit to learn more about OCBC Hong Kong.

Kenanga Investment Bank Champions Fraud Prevention and Detection in its 7th Annual Fraud Awareness Campaign

KUALA LUMPUR, MALAYSIA – Media OutReach – 14 November 2023 – Kenanga Investment Bank Berhad (“Kenanga“) proudly launches its seventh annual Fraud Awareness Week (“FAW“), reaffirming its ongoing dedication to combatting fraudulent activities and promoting ethical business practices.

Kenanga Investment Bank champions fraud prevention and detection in its 7th annual fraud awareness campaign.
Kenanga Investment Bank champions fraud prevention and detection in its 7th annual fraud awareness campaign.

Under the theme of “Embracing Disruption, Pioneering Change, Unwavering Integrity,” this year’s FAW initiative functions as a unifying platform, drawing in a diverse group of internal and external stakeholders to collaboratively bolster the fight against fraud, bribery, and corruption across all sectors.

Held in conjunction with the International FAW of the Association of Certified Fraud Examiners (“ACFE“), FAW stands as a manifestation of our unwavering commitment to combat fraud. This comprehensive month-long fraud awareness campaign features a range of virtual programmes, including the Opening Ceremony and the FAW Games, all while aligning with the United Nations Global Compact’s 10th Principle, which emphasises on the necessity for businesses to actively combat corruption in all its forms.

The FAW Games, featuring interactive anti-fraud games and quizzes, witnessed a surge in participation, marking a 16.5% increase compared to the previous year, from 376 to 438 participants who have registered. The event attracted a diverse audience, including representatives from various regulatory bodies, public listed companies, professional entities, and Kenanga’s vendors, such as Bursa Malaysia Berhad, Securities Commission Malaysia, Securities Industry Development Corporation, Kumpulan Wang Simpanan Pekerja, Institute of Corporate Directors Malaysia, Nestle Products, SP Setia, Petronas, Leadwomen, EY Malaysia as well as other notable organisations.

Notably, the event also witnessed participation from organisations based in Singapore, Indonesia, United Arab Emirates, and South Africa, including Singapore Exchange LTD, Indonesia Stock Exchange, Consultero Fzco Dubai, Western Cape Government, and several others.

During the virtual opening ceremony, Tan Sri Dato’ Seri Panglima Haji Azam bin Baki, the Chief Commissioner of Malaysian Anti-Corruption Commission (“MACC“), expressed, “It is my hope that Kenanga’s Fraud Awareness Week would serve as a platform where stakeholders come together, share insights and collectively identify effective solutions to prevent fraud and corruption. This is also in-line with the MACC’s goals of optimising collaborative efforts of all organisations to exchange information, best practices, and experiences aimed at enhancing governance.”

“Kenanga’s Fraud Awareness Week demonstrates our ongoing commitment to integrity and combating fraud across diverse industries. By fostering vigilance and collaboration, we aim to empower a community dedicated to ethical practices, ensuring a secure environment for all stakeholders,” remarked Datuk Chay Wai Leong, Kenanga Investment Bank Berhad.

“In an era where technological advancements and digital transformations continue to reshape industries, the fight against fraud has taken on new dimensions. Through Kenanga’s Fraud Awareness Week, we strive to reinforce our vigilance and preparedness, working alongside regulators and stakeholders to strengthen our defenses against emerging cyber threats. By empowering our teams and the wider community, we remain dedicated to safeguarding our operations and stakeholders from the evolving risks of fraudulent activities,” added Maheswari Kanniah, Group Chief Regulatory and Compliance Officer of Kenanga Investment Bank Berhad.

“Fraud remains a persistent threat to businesses and communities worldwide, and the need for increased vigilance and education is more critical than ever. We applaud Kenanga’s dedication to raising awareness and nurturing a culture of integrity. Through active participation in initiatives like the Fraud Awareness Week, Kenanga is proactively combating fraudulent activities and contributing to the development of a more resilient business landscape,” said John Gill, President of the Association of Certified Fraud Examiners.

Complementing this year’s FAW is a Talk Session in collaboration with the esteemed Faculty of Law of the University of Malaya (“UM“). This strategic initiative serves as a pivotal component of Kenanga’s social outreach programme, aligning with the ESG framework, aimed at enhancing the awareness of fraud prevention and detection within the local community, particularly among the students of UM’s Law Faculty. Alongside the customary FAW initiatives, this programme underscores Kenanga’s unwavering commitment to fostering governance culture and transparency throughout the organisation and within the community by prioritising ethical conduct and collective vigilance against fraudulent activities.

To view the 2023 opening ceremony and learn more about FAW, please visit: https://www.kenanga.com.my/faw.

Hashtag: #kenaga #fraudawareness #faw

The issuer is solely responsible for the content of this announcement.

Kenanga Investment Bank Berhad (197301002193 (15678-H))

Established for 50 years, Kenanga Investment Bank Berhad (“The Group“) is a financial group in Malaysia with extensive experience in equity broking, investment banking, treasury, Islamic banking, listed derivatives, investment management, wealth management, structured lending and trade financing.

An innovative and established home-grown brand, the Group’s digital ambition includes building a robust digital ecosystem that meets the needs of its clients and businesses. Some of its game-changing products include Malaysia’s fully online digital stockbroking platform Rakuten Trade and a fully A.I. robo-advisor, Kenanga Digital Investing. The Group also launched Malaysia’s first securities broking e-wallet, Kenanga Money, paved the way in AI-led Quan and algorithmic trading, kick-started a revolutionary supply chain financing solution for SMEs and made inroads into the digital assets space through its investment in Tokenize Technology (M) Sdn.Bhd.

The Group has garnered a host of awards and accolades reflecting its strong market position. It was awarded Highest Returns to Shareholder Over Three Years, Highest Growth in Profit After Tax Over Three Years and Highest Return on Equity Over Three Years by The Edge Malaysia Centurion Club in the Financial Services Category, Best Overall Equities Participating Organisation (Champion), Best Retail Equities Participating Organisation (Champion), and Best Online Retail Participating Organisation (Champion), as well as Best Institutional Derivatives Trading Participant (Champion) and Best Overall Derivatives Trading Participant (1st Runner Up) in the Bursa Excellence Awards 2022. The Group was also accorded the title of Best House, South and Southeast Asia Award in the SRP Asia Pacific Awards 2022.

The Group continues to be a regular and repeat recipient of distinguished industry accolades, such as the Lipper, Fundsupermart and Morningstar awards. Rakuten Trade, Malaysia’s first fully digital securities broker in 2017 via a joint venture with Japanese fintech giant Rakuten Securities Inc was also named Malaysia’s Digital Experience of the Year – Brokerage at the Asian Experience Awards 2022. For its continued efforts towards community outreach and employee volunteerism, the Group was awarded the coveted Bank of the Year Award for Environmental, Social & Governance Excellence, as well as Long-Standing Excellence in Sustainability at Sustainability & CSR Malaysia Awards 2022. The Group is also a Participant of the United Nations Global Compact and adheres to its principle-based approach to responsible business.

Today, Kenanga Investment Bank Berhad is an award-winning leading independent investment bank in the country with a continuous commitment towards driving collaboration, innovation, digitalisation and sustainability in the marketplace.

This Press Release was issued by Kenanga Group’s Marketing, Communications & Sustainability Department.

Vantage Data Centers Announces New Senior Leadership Appointments in Asia Pacific

Industry veterans join as president and CFO to drive further growth to keep pace with customer demand

DENVER, USA and SINGAPORE – Media OutReach – 14 November 2023 – Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced the appointment of new executive leadership in APAC to support the company’s expanding regional presence. Raymond Tong has joined Vantage as President, APAC to oversee Vantage’s business including expansion, operations and strategy in the Asia Pacific market. Tong will work closely with incoming Chief Financial Officer, APAC Joel Cheah who leads Vantage’s APAC finance and accounting teams.
Tong brings more than 25 years of business and management experience to Vantage’s APAC business. He joins the company from SUNeVision Holdings Ltd., the largest data center operator in Hong Kong, where he served for five years as chief executive officer and executive director of the board. Tong’s rich experience leading teams to scale operations and deliver key business outcomes is well suited to spearhead Vantage’s growth strategy. Prior to his time at SUNeVision Holdings, Tong held executive-level roles at several companies including Maxim’s Group and China Resources Enterprise (CRE) Ltd.
As an experienced and award-winning financial executive with a focus on real estate investment trusts (REITs), Cheah brings more than 15 years of experience navigating finance, tax regulations, capital markets and investor relations. Prior to joining Vantage, he spent more than four years serving as CFO for Elite Commercial REIT Management Pte Ltd, manager of Elite Commercial REIT, where he helped lead the company’s initial public offering (IPO) and oversaw the maiden acquisition of 58 assets for a total of £212.5 million ($257.6 million). He also previously held senior finance roles at two other listed S-REITs.
Both Tong and Cheah will be based in Singapore at the newly expanded headquarters for the Vantage APAC region.
Jeff Tench will continue in his role as executive vice president of North America and APAC and will collaborate with Tong and Cheah to advance the company’s continued growth.
“As Vantage strengthens our senior team, I look forward to working closely with Raymond and Joel to pursue new areas of growth and meet customer demand across APAC,” said Tench. “Our growing presence in the region provides a key opportunity for us to drive the creation of digital hubs to support technological advancements, and I am excited to tap into their expertise to further grow our APAC platform.”
Vantage’s APAC business has seen a significant increase in its overall footprint in the last 12 months. The company currently has seven campuses across the region that are either operational or under development. For more information on the company’s campuses in the Asia-Pacific region, please visit https://vantage-dc.com/data-center-locations/apac/.
###

For imagery of Mr. Tong and Mr. Cheah, please download here.

Hashtag: #VantageDataCenters

The issuer is solely responsible for the content of this announcement.

About Vantage Data Centers

Vantage Data Centers powers, cools, protects and connects the technology of the world’s well-known hyperscalers, cloud providers and large enterprises. Developing and operating across five continents in North America, EMEA and Asia Pacific, Vantage has evolved data center design in innovative ways to deliver dramatic gains in reliability, efficiency and sustainability in flexible environments that can scale as quickly as the market demands.

For more information, visit

Daiken Biomedical’s Lutein Secures 2023 International A.A. Clean Label Certification

Human Trials Show 190% Increase in Eye Hydration

HONG KONG SAR – Media OutReach – 14 November 2023 – Daiken Biomedical, a prominent international health food manufacturer headquartered in Taipei, is committed to creating safe, sensible, and pure health foods made with high-quality raw materials. Daiken Biomedical maintains complete transparency about its ingredients, and its products have earned numerous international certifications from the authorities in recent years. In 2023, they achieved the remarkable milestone of receiving 13 Anti-Additive Clean Label Certifications, which speaks volumes about their dedication to ensuring the purity of the ingredients used for their products.

Daiken Biomedical_EN_hk_3.png

Certified by Anti-Additive Clean Label Certification

The A.A. Clean Label (ANTI-ADDITIVE CLEAN LABEL) Certification is a rigorous global standard for certifying products free from additives. Products that receive this certification are recognised for their safety, including the absence of harmful substances and compliance with environmental and health regulations throughout their production and packaging processes.

Daiken Biomedical’s Lutein Recognised with the A.A. Clean Label Certification in 2023

In 2023, Daiken Biomedical’s flagship product, Lutein, was also certified by the A.A. Clean Label Certification in recognition of its purity and high quality. Additionally, Daiken Biomedical conducted extensive human clinical trials in partnership with international teaching hospitals and medical schools. After 18 months, Lutein demonstrated significant benefits in protecting eye health; research showed that within just 28 days, Lutein could increase the body’s lutein concentration by 520%, significantly enhancing eye moisture by 190%. These impressive results indicate Daiken Biomedical’s dedication to creating safe and effective health products. These findings were shared at the 22nd International Congress of Nutrition in Tokyo, Japan, in 2022, and the product has been awarded the Monde Selection Grand Gold Quality Award for two consecutive years, reflecting Daiken Biomedical’s exceptional commitment to health product quality.

Daiken Biomedical’s Lutein is made up of a ‘Golden Formula’ containing seven ingredients, including FloraGLO® Lutein and ZeaONE® Zeaxanthin, both backed by a wealth of research and approved by The European Food Safety Authority (EFSA). It also includes MaquiBright® Maqui Berry and BS7® Bilberry, which are rich in anthocyanins, the potent antioxidant AstaZine® Astaxanthin, flaxseed oil, and vitamin E. These ingredients work together to comprehensively support vision and eye health.

Ophthalmologist Recommends Three Steps to Select Top-Tier Lutein for Effective Dry Eye Relief

With numerous eye care products like lutein available on the market, how should consumers choose the right one? Ophthalmologist Dr. Yun-Chen Chen, from Taiwan, recommends three selection principles to determine the most effective lutein supplements for combating dry and tired eyes in today’s lifestyle, characterised by extensive use of electronic devices that rapidly depletes lutein. These guidelines help ensure the body receives the necessary nutrients.

Principle 1: Free-Form Lutein and the Optimal Ratio

Health supplements contain lutein in two forms: free-form and esterified form. Dr. Chen explains that esterified lutein requires digestive enzymes for absorption and is best taken with fats, which may not be suitable for individuals with digestive issues to consume. The molecular weight of free-form lutein is roughly half that of the esterified form; as a result, it is typically considered by the academic community to have a better absorption rate. The “Golden Ratio” refers to the optimal ratio of 10 mg of lutein to 2 mg of zeaxanthin, as determined by the five-year AREDS2 study conducted by the National Eye Institute in the U.S., to be the most beneficial for the human body. Daiken Biomedical’s Lutein is created in collaboration with the U.S.-based Kemin Industries, which possesses multiple patented technologies, to produce a product with the golden ratio of FloraGLO® free-form Lutein and ZeaONE® free-formZeaxanthin used in U.S. NIH clinical trials. Furthermore, FloraGLO® Lutein is the most effective ingredient available on the market, supported by the research. Clinical data demonstrated a 520% increase in the body’s lutein content after 28 consecutive days of consuming FloraGLO® Lutein.

Principle 2: The Benefits of Complexes of Lutein with Maqui Berry and Bilberry as Ingredients

In addition to lutein, Dr. Yun-Chen Chen suggests that combining lutein products with complex ingredients such as anthocyanins and astaxanthin can help maintain long-lasting moisture and brightness of the eyes. MaquiBright® Maqui Berry assists in regulating tear gland function and relieving dry eye symptoms, while BS7® Bilberry provides excellent antioxidant benefits, maintaining normal eye pressure and preventing night blindness. AstaZine® Astaxanthin helps reduce eye fatigue and pressure, which is beneficial for glaucoma care. Flaxseed oil and vitamin E are also excellent supporting ingredients, enhancing the body’s absorption of lutein.

Principle 3: International Awards and Certifications Indicate Superior Product Quality

Looking for high-quality lutein products with guaranteed effectiveness? Dr. Yun-Chen Chen recommends evaluating whether the product has received any awards or certifications. Daiken Biomedical’s Lutein, for example, has been awarded the Monde Selection Grand Gold Quality Award for two consecutive years after a thorough evaluation by over a hundred global experts. In terms of certification and testing, the raw materials for Lutein are sourced from American Kemin Industries, a company with 16 global patents covering seeds, production processes, and effectiveness. Additionally, it has been certified by Eurofins, an international third-party testing service provider, for being free of the Hepatitis A virus. This certification ensures food safety and instils trust in consumers. Dr. Chen also notes that lutein’s health benefits will not come into effect immediately; consistent supplementation after meals for 2 to 4 months or more is necessary for the benefits to take effect.

The biomedical research team at Daiken Biomedical, consisting of doctors and medical experts specialising in biotechnology from the United States, Japan, and Taiwan, stays true to the mottos: “safety and high quality” and “always deliver sensible results.” The team is committed to developing safe and effective health foods for you and your family. Daiken Biomedical invests over a million dollars annually in evaluation and inspection and is 100% transparent about its ingredients. Their products have repeatedly received certifications from international authorities, including 13 products, such as Lutein, that have been certified as additive-free and a total of twenty-two gold awards and trophies from Monde Selection for Many consecutive years. In the future, Daiken Biomedical will continue being dedicated to creating safe, pure, and sensible health food to help the community lead healthier lives.

The biomedical research team at Daiken Biomedical, consisting of doctors and medical experts specialising in biotechnology from the United States, Japan, and Taiwan, stays true to the mottos: “safety and high quality” and “always deliver sensible results.” The team is committed to developing safe and effective health foods for you and your family. Daiken Biomedical invests over a million dollars annually in evaluation and inspection, and is 100% transparent about their ingredients. Their products have repeatedly received certifications from international authorities, including eight products that have been certified as additive-free and a total of twenty-two gold awards and trophies from Monde Selection for many consecutive years. In the future, Daiken Biomedical will continue being dedicated to creating safe, pure, and sensible health food to help you and your family lead healthier lives.

Hashtag: #DaikenBiomedical

The issuer is solely responsible for the content of this announcement.

EquitiesFirst Podcast Series II, Episode 3: Exploring Entrepreneurship in Asia-Pacific

HONG KONG SAR – Media OutReach – 14 November 2023 – EquitiesFirst, in collaboration with The Economist Impact, is proud to present Episode 3 of our enlightening Podcast Series II: “Unlocking Entrepreneurship in Asia-Pacific.” This episode embarks on an insightful journey through the vibrant startup ecosystem emerging across the region, illuminating the pivotal role of EquitiesFirst equities-based investment in nurturing the seeds of innovation and growth.

EquitiesFirst Financing: Opportunities in Asia-Pacific’s Startup Landscape
This episode delves deep into the factors contributing to the growing startup landscape in Asia-Pacific. From the rapid advancement in communication and transportation infrastructures to the demographic shifts signifying an expanding consumer class and digitally savvy workforce, these elements are reshaping the future of business in the region. Along with EquitiesFirst equities-based financing solutions, these factors could play a part in supporting the startup climate, particularly in sectors like fintech, e-commerce, and healthtech.

EquitiesFirst Risk Management: Navigating an Evolving Financial Landscape
This episode also examines the dip in Asia-Pacific’s venture capital to a six-year low in early 2023, the support from accelerators and the public sector, and the strategies to mitigate talent gaps. Anchored by the expertise of EquitiesFirst risk management, speakers will share their insights and perspectives on how startups and investors could maneuver through these evolving financial challenges.

EquitiesFirst Partnership: A Commitment to Insightful Engagement
Through a partnership with The Economist Impact, EquitiesFirst reaffirms its commitment to delivering insightful discussions on investment trends and opportunities. The collaboration seeks to contribute to informed decision-making for investors and stakeholders interested in the Asia-Pacific equities landscape.

EquitiesFirst remains engaged in the dialogue around risk management and strategic investment, leveraging its experience to contribute to the broader conversation about the future of financing and investment in a diverse and multifaceted region like Asia-Pacific.

Hashtag: #EquitiesFirst

The issuer is solely responsible for the content of this announcement.

About Equities First Holdings

Founded in 2002, EquitiesFirst is a global investor specializing in long-term equities-based financing. EquitiesFirst’s approach overcomes traditional limitations and redefines the financing experience through providing efficient access to capital for listed companies, entrepreneurs and investors against publicly traded securities. The total value of loans transacted is more than US$4.5 billion as of January 2023.

Headquartered in Indianapolis, USA, EquitiesFirst maintains an international footprint of twelve offices in eight countries, including the United States, United Kingdom, Spain, China (Hong Kong, Shanghai and Beijing), South Korea, Thailand, Singapore and Australia (Sydney, Perth and Melbourne). EquitiesFirst is licensed and/or registered in all jurisdictions where required.

EquitiesFirst is the pioneer of Progressive Capital – a partnership approach to investment, rooted in respect, mutual interest and understanding. EquitiesFirst delivers liquidity solutions that are vital, transformative and move partners forward.

For more information, please visit .

Disclaimer
This Document is intended solely for accredited investors, sophisticated investors, professional investors, or otherwise qualified investors, as may be required by law or otherwise, and it is not intended for, and should not be used by, persons who do not meet the relevant requirements. The content provided herein is for informational purposes only and is general in nature and not targeted to any specific objective or financial need. The views and opinions expressed in this Document have been prepared by third parties and do not necessarily reflect the views and opinions of EquitiesFirst. EquitiesFirst has not independently examined or verified the information provided herein, and no representation is made that it is accurate or complete. Opinions and information herein are subject to change without notice. The content provided does not constitute an offer to sell (or solicitation of an offer to purchase) any securities, investments, or any financial products (“Offer”). Any such Offer shall only be made through a relevant offering or other documentation which sets forth its material terms and conditions. Nothing contained in this Document shall constitute a recommendation, solicitation, invitation, inducement, promotion, or offer for the purchase or sale of any investment product by First Holdings, LLC or its subsidiaries (collectively, “EquitiesFirst”), nor shall this Document be construed in any way as investment, legal, or tax advice, or as a recommendation, reference, or endorsement by EquitiesFirst. You should seek independent financial advice prior to making an investment decision about a financial product.

This Document contains the intellectual property of EquitiesFirst in the United States and other countries, including, without limitation, their respective logos and other registered and unregistered trademarks and service marks. EquitiesFirst reserves all rights in and to their intellectual property contained in this Document. The Document should not be distributed, published, reproduced or otherwise made available in whole or in part by recipients to any other person and, in particular, should not be distributed to persons in any country where such distribution may lead to a breach of any legal or regulatory requirement.

EquitiesFirst make no representation or warranty with respect to this Document and expressly disclaim any implied warranty under law. You acknowledge that EquitiesFirst is not liable under any circumstances for any direct, indirect, special, consequential, incidental, or punitive damages whatsoever, including, without limitation, any lost profits or lost opportunity, even if EquitiesFirst has been advised of the possibility of such damages.

EquitiesFirst makes the following further statements that may be applicable in the stated jurisdiction:

Australia: Equities First Holdings (Australia) Pty Ltd (ACN: 142 644 399) holds an Australian Financial Services Licence (AFSL Number: 387079). All rights reserved.

The information contained on this Document is intended for persons located in Australia only and classified as a Wholesale Client only as defined in Section 761G of the Corporations Act 2001. The distribution of information to persons outside this criteria may be restricted by law and persons who come into possession of it should seek advice and observe any such restriction.

The material contained in this Document is for information purposes only and should not be construed as an offer or solicitation or recommendation to buy or sell financial products.

The information contained in this Document is intended to be general in nature and is not personal financial product advice. Any advice contained in the Document is general advice only and has been prepared without considering your objectives, financial situation or needs. Before acting on any information, you should consider the appropriateness of the information provided and the nature of the relevant financial product having regard to your objectives, financial situation and needs. You should seek independent financial advice and read the relevant disclosure statements or other offer documents prior to making an investment decision about a financial product.

Hong Kong: Equities First Holdings Hong Kong Limited holds a Hong Kong Securities and Futures Commission Type 1 License and licensed in Hong Kong under the Money Lenders Ordinance (Money Lender’s Licence No. 1780/2022). This Document has not been reviewed by the Hong Kong Securities and Futures Commission. It is not intended as an offer to sell securities or a solicitation to buy any product managed or provided by Equities First Holdings Hong Kong Limited and is only intended for Professional Investors. This document is not directed to individuals or organizations for whom such offers or invitations would be unlawful or prohibited.

Korea: The foregoing is intended solely for professional financial consumers, professional investors or otherwise qualified investors who have sufficient knowledge and experience in entering into securities financing transactions. It is not intended for, and should not be used by, persons who do not meet that criteria.

United Kingdom: Equities First (London) Limited is authorised and regulated in the UK by the Financial Conduct Authority (“FCA”). In the UK, this Document is only being distributed and made available to persons of the kind described in Article 19(5) (investment professionals) and Article 49(2) (high net worth companies, unincorporated associations etc.) of Part IV of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (”FPO”) and any investment activity to which this presentation relates is only available to, and will only be engaged in with, such persons. Persons who do not have professional experience in matters relating to investment or who are not persons to whom Article 49 of the FPO applies should not rely on this document. This Document is only prepared for and available to persons who qualify as Professional Investors under the Markets in Financial Instruments Directive.

©2023 Equities First Holdings Hong Kong Limited. All rights reserved

Create a More Ethical Culture and Inspired Code of Conduct with NAVEX

NAVEX launches new web-based Code of Conduct

PORTLAND, Ore – News Direct – 14 November 2023 – NAVEX, the leader in integrated risk and compliance management software, today announced the launch of its new web-based Code of Conduct and subscription offering. This new capability will inspire employees to apply their organization’s values and standards while at work. Using this enhanced capability, organizations can create a more ethical workplace and build a better employee experience around their Code of Conduct in service of a stronger, more positive corporate culture.

“It’s typically a significant task to create an effective Code of Conduct that is easy to access for all employees. NAVEX has been a valuable partner and helped our team simplify the process. Their knowledgeable advisors suggested best practice code topics based on our unique risk areas,” says Dominique Desjardins, Ethics & Compliance Specialist at BRP. “This has helped us to build a code that demonstrates our commitment to ethical practices and risk mitigation.”

As a service offering, NAVEX’s solution includes access to an experienced team of risk and compliance experts that work with customers to ensure the intent of the code’s copy is right the first time. It also provides annual updates and in-depth reviews of new regulations and trends. It delivers an effective, bespoke code to customers and eliminates the need for a complete overhaul every few years.

Benefits of the NAVEX web-based Code of Conduct subscription:

  • Offers decision-making tools that link answer-seekers to helpful and relevant resources.
  • Engages employees with interactive features, embedded videos, and more. Content is fully searchable and responsive.
  • Produces analytics showing page views, visitor count, and average engagement time. These data points highlight trends that guide the business to make strategic decisions to inform training initiatives.
  • Provides a launch strategy and supporting materials such as awareness posters, supplier code, and manager’s guide.
  • Easy to access from NAVEX One, in a mobile-friendly web-based format.


NAVEX One integration

The enhanced Code of Conduct is seamlessly integrated into NAVEX One – a unified, simplified way for employees to engage with their compliance program:

  • Enables employees to conveniently report incidents.
  • Easily access and read policies, including the Code of Conduct.
  • Confirms policy adherence.
  • Access to complete training.
  • Discloses information within a user-friendly interface accessible on mobile devices.

“Forward thinking organizations want to ensure everyone is familiar with, and abides by, their Code of Conduct. Our solution makes it easy for employees to access the code and use it to guide appropriate decision making. It also keeps the code updated for business and regulatory changes,” said NAVEX Chief Product Officer, A.G. Lambert. “In addition, the web-based approach allows for analytics that help leadership understand which topics covered by the code are of the most interest and where it might need improvement or more clarity.”

To learn more about NAVEX Code of Conduct, read our blog, “How (and Why) to Make a Meaningful Code of Conduct.”

NAVEX is trusted by thousands of customers worldwide to help them achieve the business outcomes that matter most. As the global leader in integrated risk and compliance management software and services, we deliver solutions through the NAVEX One platform, the industry’s most comprehensive governance, risk and compliance (GRC) information system. For more information, visit NAVEX.com and our blog. Follow us on Twitter and LinkedIn.

Contact Details

Scott Levesque
+1 617-388-5773
scott.levesque@navex.com

Company Website

https://www.navex.com

Hashtag: #NAVEX

The issuer is solely responsible for the content of this announcement.

TJI FY2024 lnterim Revenue Up 10% Profit for the Period, excluding Government Subsidies, Surges 153%

Seeks Faster Growth through Franchise & Multi-Brand Strategy

Results Highlights

  • Group’s revenue grew 10.0% to HK$1,387.4 million, driven by 14 net openings in restaurant network and moderate comparable restaurant revenue growth in Hong Kong
  • Profit for the period excluding government subsidies(1) increased by 153.1% to HK$81.4 million
  • Operating profit margin(2) in Hong Kong stood high at 20.2%
  • Narrowed operating loss(2) outside Hong Kong by 68.3% to HK$5.3 million
  • Exploring franchise arrangements to enter Australia and the Philippines, and brand diversification in Hong Kong
  • The Board has resolved to declare an interim dividend of HK3.0 cents per share (1H2023: Nil)


Notes:

(1) This is a non-HKFRS measure, defined as profit for the relevant period deducting government subsidies, which are non-recurring income.
(2) This is a non-HKFRS measure, defined as revenue less restaurant and central kitchen costs and excluding costs attributable to headquarters and office.

HONG KONG SAR – Media OutReach – 14 November 2023 – Tam Jai International Co. Limited (“TJI” or the “Company“, and together with its subsidiaries, the “Group“; HKEX stock code: 2217), one of the leading and renowned restaurant groups in Hong Kong, today announced its interim results for the six months ended 30 September 2023 (“1H2024” or the “Period“). With new opportunities arising from the end of the pandemic, the Group has emerged stronger and delivered solid year-on-year (“YoY“) revenue growth of 10.0% to HK$1,387.4 million in 1H2024, driven by the net additions of 14 restaurants into its network and moderate comparable restaurant revenue growth in Hong Kong.

During the Period, the Group reported a narrowed operating loss(2) at the restaurant level for the combined markets outside of Hong Kong, down by 68.3% YoY to HK$5.3 million, mainly driven by the improved business performance in Mainland China and Japan.

Despite global cost inflation, the Group effectively maintained stable cost-to-revenue ratios for its food, staff and rental expenses, thanks to its streamlined workflows, agility in supply chain management, stringent cost control, as well as dedicated efforts in stabilising frontline workforce. The operating profit margin(2) of the Group’s restaurant operations increased to 18.5% in 1H2024. Profit for the period excluding government subsidies(1) increased significantly by 153.1% YoY to HK$81.4 million. Profit for the period was HK$81.6 million in 1H2024, similar to that for the six months ended 30 September 2022 (“1H2023“).

To share success with the Company’s shareholders, the Board has resolved to declare an interim dividend of HK3.0 cents per share for 1H2024 (1H2023: Nil), representing a payout ratio of approximately 49.2%.

Hong Kong Market Keeps Growing

The Group demonstrated agile, resilient, and innovative management, allowing it to maintain its prominent market position and achieve steady growth before, during, and even after the pandemic. In the past five financial years ended 31 March 2023 (“FY2023“), the Group reported a compounded annual revenue growth (CAGR) of 12.0% in Hong Kong. In 1H2024, the Group’s revenue in Hong Kong recorded a further growth of 8.2% YoY to HK$1,296.1 million, driven by the improved comparable restaurant revenue performance since the fourth quarter of FY2023, where a YoY increase of 2.9% has been recorded for 1H2024. Notable improvement was observed in commercial areas as a result of the growing number of commuters returning to their physical offices after the pandemic.

To drive further growth on the enlarged revenue base, the Group strategically expanded its product offerings with the introduction of the afternoon tea set “Me More Tea Set” in July 2023, capitalising on traditionally less busy periods and expanding its target customers to a wider base of demographics. Besides, the Group extended the business hours of its restaurants, launched attractive promotions, and engaged a new aggregator, KeeTa, to grow its comparable restaurant revenue. There were two net openings in 1H2024, with the total number of restaurants reaching 184 as of 30 September 2023.

During 1H2024, the operating profit margin(2) of the Group’s Hong Kong business improved to 20.2% (1H2023: 19.4%). This achievement further solidifies TJI’s position as one of the leading players in the food and beverages (“F&B”) sector in Hong Kong.

Narrowed Losses outside Hong Kong

In view of challenging conditions in Shenzhen due to economic slowdown, the Group made a strategic move to redirect its expansion focus to Guangzhou and other second-tier cities in the Greater Bay Area (“GBA“) in Mainland China in 1H2024. During the Period, it opened seven new restaurants in Mainland China, primarily located in Guangzhou, Dongguan, Zhongshan, and Zhuhai, while closed three underperforming stores in Shenzhen. The new restaurants, with lower operating costs, demonstrated satisfactory financial performance, contributing to 58.6% YoY increase in the Group’s revenue from the Mainland China market during 1H2024. Improved business performance also enabled the Group to narrow its operating loss in this market in 1H2024.

The Group’s business in Japan saw a YoY revenue growth of 22.2% in 1H2024, with similar growth in comparable restaurant revenue, driven by the addition of delivery channels and enhanced operational standards and efficiencies. In Singapore, the Group achieved a YoY increase of 38.8% in total revenue with one new opening in 1H2024.

Outlook: Scaling New Heights with New Business Models

Looking ahead, the Group will continue to expand its business footprint in existing and overseas markets. The Group has introduced a franchising model as it enters its inaugural Western market, Australia, and the Philippines. The potential franchises through its joint venture (“JV“) with ST Group Food Industries Holdings Limited in Australia and partnership with Suyen Corporation in the Philippines will enable TJI to reduce capital input, lowers risks, and foster a scalable business model for rapid expansion and market penetration, by leveraging the partners’ strong local know-how, experience and business network.

In Hong Kong, apart from continuously growing its two hero brands, TamJai Yunnan Mixian (譚仔雲南米線) and TamJai SamGor Mixian (譚仔三哥米線), the Group is embarking on a new venture with a multi-branding strategy. Building on the Group’s success in providing store management services for the Japanese udon brand “Marugame Seimen”, TJI has entered into a master franchise agreement with a subsidiary of Toridoll Holdings Corporation, a controlling shareholder of the Company, regarding operating restaurants under the Japanese udon brand name of “Marugame Seimen” through franchise arrangement in Hong Kong. This pilot programme is expected to pave the way for further exploration of brand portfolio diversification and driving overall business growth for the Group.

Outside of Hong Kong, the Group will continue to adjust the pace of store expansion in Mainland China and remain focused on organic growth in Singapore and Japan in the second half of this financial year. The Group is taking this opportunity to enhance localisation and branding elements to strengthen overall competitiveness, aiming to deepening market penetration and preparing for the upcoming phase of rapid expansion.

Mr. Daren Lau, Chairman, Executive Director and Chief Executive Officer of TJI, said, “We are glad to have emerged bigger, stronger and more resilient from the challenging times of the past few years. Ahead of us lies a new chapter brimming with exciting possibilities, as we enter our inaugural Western market, Australia, and the Philippines with a franchise model, while pursuing a multi-brand strategy in Hong Kong. Building on our strengthened foundation of infrastructure, management team and international operating systems, we look forward to scaling to new heights in our mission to expand our footprints across the globe.”

Hashtag: #TJI

The issuer is solely responsible for the content of this announcement.

About Tam Jai International Co. Limited (HKEX: 2217)

As one of the leading restaurant groups in Hong Kong, TJI has rapidly expanded its network to over 200 stores across various markets, including Mainland China, Singapore and Japan, with plans to enter the Australian and the Philippine markets through joint venture and/or franchising arrangements. The Group’s portfolio of distinguished brands includes TamJai Yunnan Mixian (譚仔雲南米線), TamJai SamGor Mixian (譚仔三哥米線), and the addition of the Japanese udon brand, Marugame Seimen, through franchise in Hong Kong.

With highly standardised operations, an innovative spirit and an efficient management model, TJI is committed to providing customers with a quality yet affordable dining experience while ambitiously expanding its footprints across the globe. The Group has been listed on The Stock Exchange of Hong Kong Limited (stock code: 02217.HK) since October 2021.

Else Nutrition and Danone Enter into a Binding Multi-Stage Collaboration

Vancouver, British Columbia – Newsfile Corp. – November 13, 2023 – ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), is pleased to announce that it has agreed to a multi-staged collaboration with Danone S.A., a worldwide leading company specializing in fresh dairy products, plant-based, water and specialized nutrition.

Else and Danone signed a letter of intent (“LOI”) on November 13, 2023 providing for a multi-stage collaboration subject to the finalization of certain commercial terms. The LOI was entered into following Danone having completed extensive due diligence.

At the first stage of the collaboration, Else and Danone will enter into a License Agreement whereby Else’s products, which are plant based, soy-free and supported by clinical evidence, shall be included in Danone’s specialized nutrition portfolio and manufactured, marketed and commercialized by Danone. In addition to the first stage, the parties shall negotiate other opportunities beyond product commercialization.

The Parties anticipate signing the definitive agreement by the end of Q1, 2024.

About Danone S.A.

Dedicated to bringing health through food to as many people as possible, Danone is a leading global food & beverage company built on four businesses: Essential Dairy and Plant-Based Products, Waters, Early Life Nutrition and Medical Nutrition.

Danone aims to inspire healthier and more sustainable eating and drinking practices, in line with their vision – Danone, One Planet. One Health – which reflects a strong belief that the health of people and the health of the planet are interconnected. Danone deliberately concentrates on high-growth and health-focused categories and commits to operating in an efficient, sustainable, and responsible manner.

This unique approach, historically defined as their Dual Project, enables Danone to create both shareholder and societal value. Danone holds itself to the highest standards, as reflected by the ambition to become one of the first multinationals certified as B CorpTM.

With products sold in over 120 markets, Danone generated sales of €27.661 billion in 2022. Danone’s portfolio includes brands present worldwide (Activia, Actimel, Alpro, Danette, Danonino, Danio, evian, Volvic, Nutrilon/Aptamil, Nutricia) and in their local markets (Aqua, Blédina, Cow & Gate, Bonafont, Horizon Organic, Mizone, Oikos, Silk).

Listed on Euronext Paris and on the OTCQX market via an ADR (American Depositary Receipt) program, Danone is a component stock of leading social responsibility indexes including the Dow Jones Sustainability Indexes, Vigeo, the Ethibel Sustainability Index, MSCI Global Sustainability, MSCI Global SRI Indexes and the FTSE4Good Index.

To delve deeper into Else Nutrition’s offerings and its revolutionary approach to kids’ nutrition, visit www.elsenutrition.com

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:

  • “2017 Best Health and Diet Solutions” award at Milan’s Global Food Innovation Summit
    • #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
    • “Best Dairy Alternative” Award 2021 at World Plant-Based Expo
    • Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
    • During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon


Investor Relations Contact:

Crescendo Communications, LLC
Alexandra Schilt
Office: (212) 671-1020 Ext: 305
Email: baby@crescendo-ir.com

Lytham Partners, LLC Mr. Ben Shamsian New York | Phoenix Office: (646)829-9701
E: shamsian@lythampartners.com

TSX

Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of pandemics or other global circumstances and that the manufacturing, broker, and supply logistic agreements with the company do not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward- looking statements, which reflect management’s expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Hashtag: #ElseNutrition

The issuer is solely responsible for the content of this announcement.